Monoclonal antibody drug production in India at reasonable price could be a game changer for the country in its fight against COVID-19, said Dr Arvinder S Soi
New Delhi [India], May 30 (ANI): Monoclonal antibody drug production in India at reasonable price could be a "game changer" for the country in its fight against COVID-19, said Dr Arvinder S Soin, Chairman, Institute of Liver Transplant and Regenerative Medicine at Medanta Hospital on Sunday.
India News: NEW DELHI: Last week, an 84-year-old man from Haryana was administered the "famous" anti-Covid cocktail that was also given to former US President Don.
The therapy is a mix of two ‘monoclonal antibodies’, or proteins, that are artificially created in a laboratory and tailor-made to fight a particular disease, in this cases, Covid-19
Antibody cocktail is said to reduce the chance of hospitalisation by 70 per cent in patients with mild to moderate Covid-19 symptoms. Here is all you need to know about the therapy